MARSHALL WACE, LLP - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 189 filers reported holding ANI PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,172,741
+837.9%
89,093
+769.5%
0.01%
+900.0%
Q2 2023$551,542
+24.0%
10,246
-8.5%
0.00%0.0%
Q1 2023$444,824
-78.4%
11,199
-74.9%
0.00%
-75.0%
Q4 2021$2,055,000
+28.9%
44,600
+97.3%
0.00%
-50.0%
Q1 2019$1,594,000
+51.8%
22,606
+21.7%
0.01%
+100.0%
Q3 2018$1,050,00018,5780.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Mesirow Financial Investment Management, Inc. 9,433$266,0001.14%
Global Alpha Capital Management Ltd. 258,946$7,305,0001.12%
Birch Grove Capital LP 50,791$1,433,0000.78%
1492 Capital Management LLC 25,003$705,0000.53%
INVESTMENT COUNSELORS OF MARYLAND LLC 321,975$9,083,0000.41%
THB ASSET MANAGEMENT 48,385$1,364,0000.38%
Regent Investment Management LLC 36,979$1,043,0000.32%
GLOBEFLEX CAPITAL L P 41,212$1,163,0000.31%
HUSSMAN STRATEGIC ADVISORS, INC. 35,500$1,001,0000.26%
Ranger Investment Management 124,763$3,520,0000.22%
View complete list of ANI PHARMACEUTICALS INC shareholders